Expeditors International of Wshngtn Inc vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Expeditors International of Wshngtn Inc trades at $196.77 (market cap $25.53B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $13 (market cap $10.61B). The key difference: Expeditors International of Wshngtn Inc is far larger — about 2.4× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and Expeditors International of Wshngtn Inc pays the higher dividend (0.82%). Which is the better fit depends on your goals — on Pluang, investors hold Expeditors International of Wshngtn Inc for 44 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| EXPD | RDY | |
|---|---|---|
Market Cap | $25.53B | $10.61B |
Volume | 1,068,336 | 3,738,869 |
Sector | Industrials | Health |
52-Week High | $196.38 | $15.38 |
52-Week Low | $117.35 | $11.38 |
Typical Hold Time | 44 Days | 0 Days |
Enterprise Value | $25.06B | $10.51B |
Dividend Yield | 0.82% | 0.65% |
Signals from Pluang's Aura AI — not financial advice
EXPD trades at $195.13, up 0.89% with a bullish technical signal supported by moving averages. The company shows strong profitability with 7.63% net margin and 42.6% ROE, though revenue growth has been modest. Recent earnings beats and positive analyst coverage highlight operational efficiency, while institutional activity shows mixed positioning.
Outlook remains cautiously optimistic with upside to the $220 high target, but valuation multiples appear stretched. Key risks include freight market volatility and competitive pressures. The stock's current price above consensus target suggests limited near-term upside despite strong fundamentals.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. In 2021, Expeditors derived 38% of consolidated net revenue from airfreight, 27% from ocean freight, and 35% from customs brokerage and other services.
Read more on EXPD →Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →